JJ

Jenna Leigh Jeffrey

AB Arcus Biosciences: 10 patents #10 of 66Top 20%
📍 Oakland, CA: #577 of 4,380 inventorsTop 15%
🗺 California: #55,401 of 386,348 inventorsTop 15%
Overall (All Time): #430,811 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12410170 2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds Joel Worley Beatty, Samuel Lawrie Drew, Jeremy Thomas Andre Fournier, Kenneth V. Lawson, Manmohan Reddy Leleti +7 more 2025-09-09
12384773 Thiazole compounds and methods of use thereof Srijita Bhowmik, Karen Yir Jing Chen, Manjunath Lamani, Manmohan Reddy Leleti, Guillaume Mata +7 more 2025-08-12
12195447 Azolopyrimidine for the treatment of cancer-related disorders Joel Worley Beatty, Laurent P. Debien, Manmohan Reddy Leleti, Debashis Mandal, Dillon Harding Miles +4 more 2025-01-14
12103907 Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha Joel Worley Beatty, Samuel Lawrie Drew, Matthew Epplin, Jeremy Thomas Andre Fournier, Balint Gal +19 more 2024-10-01
11993584 Solid forms of an azolopyrimidine compound Manmohan Reddy Leleti, Dillon Harding Miles, Jay P. Powers 2024-05-28
11931343 CD73 inhibitors Joel Worley Beatty, Laurent P. Debien, Samuel Lawrie Drew, Jeremy Thomas Andre Fournier, Rebecca Grange +9 more 2024-03-19
11819512 Solid forms of a CD73 inhibitor and the use thereof Kenneth V. Lawson, Dillon Harding Miles 2023-11-21
11787762 Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha Joel Worley Beatty, Samuel Lawrie Drew, Matthew Epplin, Jeremy Thomas Andre Fournier, Balint Gal +19 more 2023-10-17
11407712 Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α Joel Worley Beatty, Samuel Lawrie Drew, Matthew Epplin, Jeremy Thomas Andre Fournier, Balint Gal +19 more 2022-08-09
11072597 Azolopyrimidine for the treatment of cancer-related disorders Joel Worley Beatty, Laurent P. Debien, Manmohan Reddy Leleti, Debashis Mandal, Dillon Harding Miles +4 more 2021-07-27
10399962 Azolopyrimidine for the treatment of cancer-related disorders Joel Worley Beatty, Laurent P. Debien, Manmohan Reddy Leleti, Debashis Mandal, Dillon Harding Miles +4 more 2019-09-03